"ImmuONE Secures £600K to Enhance Ethical Testing Methods"
Summary
In a groundbreaking move, ImmuONE, a dynamic biotech startup based in Stevenage, UK, has successfully raised \xa3600K in funding to revolutionize the realm of animal testing. With the backing of these empowered investors, ImmuONE is set to redefine how industries approach testing in an ethical and efficient manner.The funds will be strategically utilized to enhance ImmuONEs capabilities and expand into new sectors, including agrichemicals and automotive.Additionally, the company plans to bolster its team by bringing on two new experts in the field. Founded in 2019 by visionary leaders Dr. Abigail Martin and Professor Victoria Hutter from the University of Hertfordshire, ImmuONE is at the forefront of biotech innovation, offering a sophisticated 3D human lung model that significantly reduces the reliance on animal testing. This model not only supports respiratory safety assessments but also incorporates advanced immunology tests that evaluate the long-term effects of various substances on lung health.As ImmuONE continues to grow, the company has also attracted new clients within the chemicals sector, effectively expanding its existing clientele that includes notable consumer products and pharmaceutical companies. As more investors recognize the critical importance of sustainable practices, ImmuONE stands poised not just to make an impact in the biotech industry but to lead the charge towards an animal-friendly future in scientific research.